Selected research
Industry Research
Gastric Cancer Diagnostic Procedure Industry Research Report 2026
Market perspective
The global Gastric Cancer Diagnostic Procedure market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Gastric Cancer Diagnostic Procedure market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Gastric Cancer Diagnostic Procedure market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Gastric Cancer Diagnostic Procedure market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Gastric Cancer Diagnostic Procedure include Pfizer Inc., Johnson & Johnson Co, F.Hoffmann La Roche, Merck & Co. Ilnc, Bayer AG, Novartis AG, Bristol-Myers Squibb Company, ThermoFisher Scientific Inc and AstraZeneca plc, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Gastric Cancer Diagnostic Procedure market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Gastric Cancer Diagnostic Procedure.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gastric Cancer Diagnostic Procedure Market by Company
Pfizer Inc.
Johnson & Johnson Co
F.Hoffmann La Roche
Merck & Co. Ilnc
Bayer AG
Novartis AG
Bristol-Myers Squibb Company
ThermoFisher Scientific Inc
AstraZeneca plc
Abbott Laboratories Inc
Sanof SA
Eli Lilly and Company
OtsukaPharmaceutical Co Ltd
AdventHealth, Atrium Health
Astellas Pharma Inc
Bausch Health Companies Inc
Gastric Cancer Diagnostic Procedure Segment by Type
Instrument
Test Strips and Consumables
Service
Gastric Cancer Diagnostic Procedure Segment by Application
Early Gastric Cancer
Advanced Gastric Cancer
Gastric Cancer Diagnostic Procedure Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastric Cancer Diagnostic Procedure market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gastric Cancer Diagnostic Procedure and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastric Cancer Diagnostic Procedure.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Gastric Cancer Diagnostic Procedure companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Instrument
- Test Strips and Consumables
- Service
Applications
- Early Gastric Cancer
- Advanced Gastric Cancer
Companies covered
- Pfizer Inc.
- Johnson & Johnson Co
- F.Hoffmann La Roche
- Merck & Co. Ilnc
- Bayer AG
- Novartis AG
- Bristol-Myers Squibb Company
- ThermoFisher Scientific Inc
- AstraZeneca plc
- Abbott Laboratories Inc
- Sanof SA
- Eli Lilly and Company
- OtsukaPharmaceutical Co Ltd
- AdventHealth, Atrium Health
- Astellas Pharma Inc
- Bausch Health Companies Inc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Gastric Cancer Diagnostic Procedure by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Instrument
- 2.2.3 Test Strips and Consumables
- 2.2.4 Service
- 2.3 Gastric Cancer Diagnostic Procedure by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Early Gastric Cancer
- 2.3.3 Advanced Gastric Cancer
- 2.4 Assumptions and Limitations
3 Gastric Cancer Diagnostic Procedure Breakdown Data by Type
- 3.1 Global Gastric Cancer Diagnostic Procedure Historic Market Size by Type (2021-2026)
- 3.2 Global Gastric Cancer Diagnostic Procedure Forecasted Market Size by Type (2027-2032)
4 Gastric Cancer Diagnostic Procedure Breakdown Data by Application
- 4.1 Global Gastric Cancer Diagnostic Procedure Historic Market Size by Application (2021-2026)
- 4.2 Global Gastric Cancer Diagnostic Procedure Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Gastric Cancer Diagnostic Procedure Market Perspective (2021-2032)
- 5.2 Global Gastric Cancer Diagnostic Procedure Growth Trends by Region
- 5.2.1 Global Gastric Cancer Diagnostic Procedure Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Gastric Cancer Diagnostic Procedure Historic Market Size by Region (2021-2026)
- 5.2.3 Gastric Cancer Diagnostic Procedure Forecasted Market Size by Region (2027-2032)
- 5.3 Gastric Cancer Diagnostic Procedure Market Dynamics
- 5.3.1 Gastric Cancer Diagnostic Procedure Industry Trends
- 5.3.2 Gastric Cancer Diagnostic Procedure Market Drivers
- 5.3.3 Gastric Cancer Diagnostic Procedure Market Challenges
- 5.3.4 Gastric Cancer Diagnostic Procedure Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Gastric Cancer Diagnostic Procedure Players by Revenue
- 6.1.1 Global Top Gastric Cancer Diagnostic Procedure Players by Revenue (2021-2026)
- 6.1.2 Global Gastric Cancer Diagnostic Procedure Revenue Market Share by Players (2021-2026)
- 6.2 Global Gastric Cancer Diagnostic Procedure Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Gastric Cancer Diagnostic Procedure Head Office and Area Served
- 6.4 Global Gastric Cancer Diagnostic Procedure Players, Product Type & Application
- 6.5 Global Gastric Cancer Diagnostic Procedure Manufacturers Established Date
- 6.6 Global Gastric Cancer Diagnostic Procedure Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Gastric Cancer Diagnostic Procedure Market Size (2021-2032)
- 7.2 North America Gastric Cancer Diagnostic Procedure Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
- 7.4 North America Gastric Cancer Diagnostic Procedure Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Gastric Cancer Diagnostic Procedure Market Size (2021-2032)
- 8.2 Europe Gastric Cancer Diagnostic Procedure Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
- 8.4 Europe Gastric Cancer Diagnostic Procedure Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size (2021-2032)
- 9.2 Asia-Pacific Gastric Cancer Diagnostic Procedure Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Gastric Cancer Diagnostic Procedure Market Size (2021-2032)
- 10.2 South America Gastric Cancer Diagnostic Procedure Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
- 10.4 South America Gastric Cancer Diagnostic Procedure Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size (2021-2032)
- 11.2 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Pfizer Inc.
- 12.1.1 Pfizer Inc. Company Information
- 12.1.2 Pfizer Inc. Business Overview
- 12.1.3 Pfizer Inc. Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.1.4 Pfizer Inc. Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.1.5 Pfizer Inc. Recent Developments
- 12.2 Johnson & Johnson Co
- 12.2.1 Johnson & Johnson Co Company Information
- 12.2.2 Johnson & Johnson Co Business Overview
- 12.2.3 Johnson & Johnson Co Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.2.4 Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.2.5 Johnson & Johnson Co Recent Developments
- 12.3 F.Hoffmann La Roche
- 12.3.1 F.Hoffmann La Roche Company Information
- 12.3.2 F.Hoffmann La Roche Business Overview
- 12.3.3 F.Hoffmann La Roche Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.3.4 F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.3.5 F.Hoffmann La Roche Recent Developments
- 12.4 Merck & Co. Ilnc
- 12.4.1 Merck & Co. Ilnc Company Information
- 12.4.2 Merck & Co. Ilnc Business Overview
- 12.4.3 Merck & Co. Ilnc Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.4.4 Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.4.5 Merck & Co. Ilnc Recent Developments
- 12.5 Bayer AG
- 12.5.1 Bayer AG Company Information
- 12.5.2 Bayer AG Business Overview
- 12.5.3 Bayer AG Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.5.4 Bayer AG Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.5.5 Bayer AG Recent Developments
- 12.6 Novartis AG
- 12.6.1 Novartis AG Company Information
- 12.6.2 Novartis AG Business Overview
- 12.6.3 Novartis AG Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.6.4 Novartis AG Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.6.5 Novartis AG Recent Developments
- 12.7 Bristol-Myers Squibb Company
- 12.7.1 Bristol-Myers Squibb Company Company Information
- 12.7.2 Bristol-Myers Squibb Company Business Overview
- 12.7.3 Bristol-Myers Squibb Company Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.7.4 Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.7.5 Bristol-Myers Squibb Company Recent Developments
- 12.8 ThermoFisher Scientific Inc
- 12.8.1 ThermoFisher Scientific Inc Company Information
- 12.8.2 ThermoFisher Scientific Inc Business Overview
- 12.8.3 ThermoFisher Scientific Inc Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.8.4 ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.8.5 ThermoFisher Scientific Inc Recent Developments
- 12.9 AstraZeneca plc
- 12.9.1 AstraZeneca plc Company Information
- 12.9.2 AstraZeneca plc Business Overview
- 12.9.3 AstraZeneca plc Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.9.4 AstraZeneca plc Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.9.5 AstraZeneca plc Recent Developments
- 12.10 Abbott Laboratories Inc
- 12.10.1 Abbott Laboratories Inc Company Information
- 12.10.2 Abbott Laboratories Inc Business Overview
- 12.10.3 Abbott Laboratories Inc Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.10.4 Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.10.5 Abbott Laboratories Inc Recent Developments
- 12.11 Sanof SA
- 12.11.1 Sanof SA Company Information
- 12.11.2 Sanof SA Business Overview
- 12.11.3 Sanof SA Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.11.4 Sanof SA Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.11.5 Sanof SA Recent Developments
- 12.12 Eli Lilly and Company
- 12.12.1 Eli Lilly and Company Company Information
- 12.12.2 Eli Lilly and Company Business Overview
- 12.12.3 Eli Lilly and Company Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.12.4 Eli Lilly and Company Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.12.5 Eli Lilly and Company Recent Developments
- 12.13 OtsukaPharmaceutical Co Ltd
- 12.13.1 OtsukaPharmaceutical Co Ltd Company Information
- 12.13.2 OtsukaPharmaceutical Co Ltd Business Overview
- 12.13.3 OtsukaPharmaceutical Co Ltd Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.13.4 OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.13.5 OtsukaPharmaceutical Co Ltd Recent Developments
- 12.14 AdventHealth, Atrium Health
- 12.14.1 AdventHealth, Atrium Health Company Information
- 12.14.2 AdventHealth, Atrium Health Business Overview
- 12.14.3 AdventHealth, Atrium Health Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.14.4 AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.14.5 AdventHealth, Atrium Health Recent Developments
- 12.15 Astellas Pharma Inc
- 12.15.1 Astellas Pharma Inc Company Information
- 12.15.2 Astellas Pharma Inc Business Overview
- 12.15.3 Astellas Pharma Inc Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.15.4 Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.15.5 Astellas Pharma Inc Recent Developments
- 12.16 Bausch Health Companies Inc
- 12.16.1 Bausch Health Companies Inc Company Information
- 12.16.2 Bausch Health Companies Inc Business Overview
- 12.16.3 Bausch Health Companies Inc Revenue in Gastric Cancer Diagnostic Procedure Business (2021-2026)
- 12.16.4 Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Product Portfolio
- 12.16.5 Bausch Health Companies Inc Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst